Sarcoma Clinical Trial - A Clinical Study on Oncolytic Virus Injection

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04457258` - 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma	Early Phase 1
Recruiting	`NCT04986748` - Using QPOP to Predict Treatment for Sarcomas and Melanomas
Completed	`NCT04474678` - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")	N/A
Recruiting	`NCT05415098` - Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas	Phase 1
Recruiting	`NCT04535713` - GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma	Phase 2
Completed	`NCT03521531` - Burden and Medical Care of Sarcoma in Germany
Completed	`NCT02496520` - Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults	Phase 1/Phase 2
Terminated	`NCT02054104` - Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum	Phase 1/Phase 2
Terminated	`NCT00788125` - Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT04577014` - Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma	Phase 1/Phase 2
Active, not recruiting	`NCT04383210` - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors	Phase 2
Completed	`NCT04052334` - Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma	Phase 1
Completed	`NCT01593748` - A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma	Phase 2
Completed	`NCT00199849` - NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine	Phase 1
Recruiting	`NCT04367779` - Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.
Completed	`NCT01879085` - Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma	Phase 1/Phase 2
Recruiting	`NCT04553692` - Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers	Phase 1
Completed	`NCT01209598` - PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma	Phase 2
Completed	`NCT04553471` - Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers	N/A
Withdrawn	`NCT04906876` - A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas	Phase 2

NCT number	NCT06171282
Study type	Interventional
Source	Shanghai Yunying Medical Technology
Contact	Pan Feng, MD
Phone	+8613764868528
Email	pf@jxyymedtech.com
Status	Recruiting
Phase	Early Phase 1
Start date	July 12, 2023
Completion date	July 12, 2026

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms